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or dysfunctionAbstract Left ventricular (LV) dysfunction caused by frequent premature ventricular complexes
(PVCs) can be reversed by suppression of PVCs with antiarrhythmic agents or radiofrequency cath-
eter ablation (RFA). However, there is a paucity of data on the efﬁcacy and safety of RFA among
the local population. We aimed in this study to evaluate the effect of RFA of frequent PVCs orig-
inating from right ventricular outﬂow tract (RVOT-PVCs) on cardiac function in patients with
depressed cardiac function and/or LV dilation. The study included sixteen patients with monomor-
phic RVOT-PVCs without overt underlying structural heart disease. Frequency of PVCs by 24-h
Holter monitoring, left ventricular ejection fraction (LVEF), end-diastolic diameter (LVEDD),
end-systolic diameter (LVESD), mitral regurgitation (MR) by echocardiogram and NYHA func-
tional class were evaluated before and 3 and 6 months after RFA. All patients underwent RFA.
Results: The higher the number of PVCs/24 h, the bigger the LVESD and the lower the EF. Pro-
cedural success was achieved in 13 (81%) of the patients with no complications. Six months follow-
up after successful ablation, LVEDD decreased signiﬁcantly (from 56.62 ± 5.87 to 49.23 ±
5.31 mm; p= 0.002), LVESD decreased signiﬁcantly (from 41.85 ± 7.82 to 33.69 ± 4.66 mm;
p= 0.002), LVEF increased signiﬁcantly (from 46.69 ± 4.92% to 60.54 ± 5.39%; p< 0.001)
and NYHA functional class improved in all patients after successful ablation.
352 T. Basiouny et al.Conclusion: RF catheter ablation of frequent RVOT-PVC has a beneﬁcial effect on cardiac func-
tion in patients with depressed cardiac function.
It carries a high degree of success and safety. Frequent RVOT-PVCs are burden on LV function
even in patients without overt underlying structural heart disease.
ª 2014 Production and hosting by Elsevier B.V. on behalf of Egyptian Society of Cardiology.1. Introduction
Premature ventricular contractions (PVCs) are early depolar-
ization of the myocardium originating in the ventricle. They
are often seen in association with structural heart disease
and represent increased risk of sudden death, yet they are ubiq-
uitous, even in the absence of identiﬁable heart disease.1,2 They
may cause troubling and sometimes incapacitating symptoms
such as palpitation, chest pain, presyncope, syncope, and heart
failure.3 Idiopathic ventricular arrhythmias (VA) consist of
various subtypes of VA that occur in the absence of clinically
apparent structural heart disease. Affected patients account for
approximately 10% of all patients referred for evaluation of
ventricular tachycardia (VT).4 Arrhythmias arising from the
outﬂow tract (OT) are the most common subtype of idiopathic
VA and more than 70–80% of idiopathic VTs or (PVCs) orig-
inate from the right ventricular (RV) OT.5 Traditionally, PVCs
have been thought to be relatively benign in the absence of
structural heart disease,6 but in retrospective analyses prema-
ture ventricular complexes have been implicated as a cause
of impaired left ventricular function.2 Also frequent isolated
ectopic beats, mostly originating from the right ventricular
outﬂow tract have been reported as a cause of tachycardiomy-
opathy, a reversible form of congestive heart disease that re-
solves after elimination of the culprit arrhythmia either by
medical treatment or by Radiofrequency Ablation (RFA).7
Various therapeutic options for ventricular arrhythmias in-
clude antiarrhythmic drugs, antiarrhythmic surgery and place-
ment of an implantable cardioverter deﬁbrillator (ICD) for
VT, or radiofrequency catheter ablation.8 When highly symp-
tomatic and refractory to antiarrhythmic therapy or causative
for ventricular dysfunction, ablation is a recommended treat-
ment for right ventricular outﬂow tract PVCs (RVOT-PVCs)
with a high success rate and a low risk of complications.9
2. Aim of the work
This study was undertaken to evaluate the effect of RF abla-
tion of frequent premature ventricular complexes from right
ventricular outﬂow tract (RVOT-PVCs) on cardiac function
in patients with depressed cardiac function and to examine
whether frequent RVOT-PVCs without overt underlying struc-
tural heart disease correlates with LV dilation, which is a
well-recognized precursor of LV dysfunction and congestive
heart failure or not.
3. Patients and methods
The study was conducted at the Cardiology department of our
institute from February, 2011 to September, 2013. Patients en-
rolled in this study when they have symptomatic monomorphic
RVOT-PVCs associated with LV dilation (LVEDD P59 mm
and/or LVESDP41 mm) and/or impaired LV systolic function(EF 650%) without overt underlying structural heart disease.
RVOT-PVC was deﬁned as a characteristic electrocardiographic
appearance of a left bundle branch block (LBBB) contour in V1
and an inferior axis in the frontal plane. We excluded patients
with the history of recent myocardial infarction, patients with
ECG evidence of myocardial infarction, patients with known
coronary stenosis of >50% diameter, patients with segmental
dyskinetic regions by Echocardiography, patients with signiﬁ-
cant valvular heart disease, patients with congenital heart
disease, patients with RV abnormalities, Patients with atrial
tachyarrhythmia including AF, atrial ﬂutter, atrial tachycardia,
and paroxysmal supraventricular tachycardia and any patient
unwilling to have the procedure. LVOT-PVCs diagnosed
according to Betensky’s algorithm,10 which utilized the 12-leads
surface ECG for PVC localization, were excluded from the
study.
All patients signed an informed consent after discussing the
procedures and possible alternatives and complications. All
patients were subjected to through clinical examination, history
taking and routine laboratory analysis. Chest radiogram in PA
view was done for the measurement of CT ratio and detection
of cardiomegaly. Resting 12-Leads surface ECG was
performed to detect morphology of PVCs (if frequent) and to
exclude evidence of myocardial infarction or evidence of other
arrhythmia. Resting Trans-Thoracic Echocardiography (TTE)
was undertaken (with the patient lying in the left lateral decu-
bitus using the standard views) on admission, 3 and 6 months
after the successful RF ablation. From TTE we can estimate
chamber size of LV and right ventricle (RV), Degree of mitral
regurgitation (at parasternal long-axis or apical four-chamber
view) and Left ventricular ejection fraction (LVEF) which
was calculated using the Teichholz method. All values of echo-
cardiogram were recorded during sinus rhythm, but not at the
PVC beat, nor at the post-PVC beat. All patients also had rou-
tine echocardiogram on the next day of RFA to evaluate the
possible procedure related complications. 24-h Holter monitor-
ing was done to all patients before RFA, within 48 h after RFA,
3 and 6 months thereafter and whenever there are signiﬁcant
symptoms during follow up period to exclude recurrence. The
%PVC was calculated as: 100Æ[number of PVC/number of total
heart beats per 24 h]. Coronary angiography (CAG) was done
for high risk patients to exclude ischemic heart disease, and
exercise stress test (ETT) was done for low and intermediate
risk patients for the same purpose.
Electrophysiological study, mapping and catheter ablation
were done by the conventional method. The patients were
studied in the fasting state without sedation. Antiarrhythmic
drugs were discontinued for at least six half-lives before the
procedure. Under local anesthesia, two 7-F deﬂectable quadri-
polar ablation catheters with a 4-mm-tip electrode and 5 mm
interelectrode distance were introduced percutaneously into
the RV. One of the two catheters was used ﬁrst to make a land
mark for the His position. The ablation catheter was
introduced to the RVOT guided by both LAO and RAO
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history is suggesting VT or if they have a documented VT
(either sustained or non-sustained) recorded by 12-leads
ECG or during Holter monitoring. Mapping procedure was
started by looking for the earliest local ventricular activation
of PVCs 20–60 ms before the onset of QRS complex in V1
of the simultaneously recorded ECG. Roving technique, some-
times was used by the two ablation catheters, the ﬁrst catheter
was moved to ﬁnd the earliest ventricular activation site and
the second ablation catheter was moved to ﬁnd an earlier
ventricular activation than the ﬁrst. This maneuver was re-
peated until the earliest ventricular activation site of PVCs
was found (Fig. 1). Bipolar pace mapping (of 2 ms pulse width
at double the diastolic threshold) was used immediately before
applying RF current at the culprit site of ablation in order to
match the 12 leads ECG obtained during pacing with the spon-
taneous PVCs of the patient. An identical match was necessary
in at least 11 of 12 leads.Figure 1 Shows earliest ventricular activation site at the ablation
intracardiac recording by the ablation catheter.Epinephrine administration and/or programmed electrical
stimulation was performed to induce the culprit PVC. If the
culprit PVCs were infrequent at the time of the study a combi-
nation of activation and pace mapping was used to identify the
optimal target site of ablation in order to prevent prolongation
of procedure time. RFA was delivered for 60–90 s at the site
that poses an identical paced 12-lead ECG match.
During mapping for earliest ventricular activation RFA
was also performed for 60–90 s. If the culprit PVCs did not dis-
appear after the 10 s ablation stopped searching for another
site was attempted.
A successful ablation was deﬁned as no recurrence and non-
inducibility of culprit PVC with and without programmed elec-
trical stimulation for at least 30 min after ablation. All 12-leads
surface electrocardiograms and the bipolar intracardiac electro-
grams (ﬁltered at 30–400 Hz) were recorded and stored by using
the channel acquisition system. During the procedure, intrave-
nous heparin was given as a 70 IU/kg bolus dose followed bycatheter 49 ms before culprit PVC. ECG leads I, aVF, V1 and
354 T. Basiouny et al.boluses of 1000 IU every hour. All patients received oral anti-
platelets for 6 weeks after RFA, but no antiarrhythmic drugs.
The standard of instant success is as follows: When PVCs
disappear or when sporadic PVCs 61 beats/min, VT cannot
be induced after radiofrequency ablation, when close observa-
tion for 30 min after procedure reveals a reduction of the total
number of PVCs to less than 10 (shape is completely similar to
monomorphic PVCs before procedure).11
It should be conﬁrmed in all cases that the PVC was not
caused mechanically and that it coincided with the morphol-
ogy of the clinical PVC. An increase in ectopic activity may
be observed to precede termination of the application. Some-
times, at successful ablation site when applying RF, accelera-
tion of tachycardia may occur before its termination.
The standard of long-term success is whenHolter ECGmon-
itoring for a full day within 3 months after successful procedure
shows that PVCs disappeared, or when total number of PVCs
decreased by over 75%.Moreover, long-term success is achieved
when the uncomfortable symptoms are remarkably improved.11
4. Statistical analysis
Clinical and electrophysiological variables were recorded and a
descriptive analysis was done. Data were collected on a special
format, veriﬁed and then coded when needed prior to analysis.
All continuous data were expressed as mean ± SD unless
otherwise needed, categorical data were expressed as frequency
in tables. Enumeration data are described as case numbers and
percentages. Chi-square test for assessing association in cate-
gorical data was performed. p-value <0.05 was considered
signiﬁcant. Nonparametric tests were used for correlation
between different variables. All analysis had been performed
using Statistical Package for Social Sciences (SPSS) version
10 for Windows and graphics by MS Excel.
5. Results
Sixteen patients fulﬁlled the inclusion criteria described previ-
ously in the methodology, baseline characteristics of the patient
population are summarized in Table 1. Three patients with high
risk of IHD had normal coronary angiography. Thirteen
patients with low risk of IHD were subjected to exercise test,
two of them developed short runs of VT during exercise that
required termination of the test and referred for CAG which
was found normal. PVCs frequency increased in ﬁve patients
and disappeared in the rest of patients at peak exercise.Table 1 Baseline characteristics of the studied population.
N Minimu
Age 16 13.00
Duration of symptoms in months 16 12
EDD before ablation/mm 16 40
ESD before ablation/mm 16 24
EF before ablation 16 34
Number of PVCs before ablation/24 h 16 8698
Total number of heart beats/24 h 16 71,535
% of PVCs 16 7.00
EDD, end-diastolic diameter; ESD, end-systolic diameter; EF, ejection frThe age ranged from 13 to 53 years and the mean age was
34 ± 12, the total number of females was 11(69%). All pa-
tients included in the study had PVCs-associated symptoms,
seven patients were complaining of Dyspnea, six patients from
syncope and two patients from palpitation while the remaining
patient was complaining of chest pain. All patients had been
taking antiarrhythmic agents before admission. The duration
of symptoms in months for each patient was reported. It
ranged from 12 to 46 months and the mean duration was
25.13 ± 11.43. Eleven patients (69%) were in NYHA func-
tional class II and ﬁve patients (31%) in class III. Detailed
mapping of the right ventricular OT was performed in the 16
patients. In 1 patient ventricular ectopy was infrequent and re-
quired intensive pace mapping with searching for an identical
paced 12-leads ECG match. None of the patients had absent
PVCs at the time of the study. Procedural acute success was
achieved in 13 patients (81%) of the 16 patients, and no proce-
dure-related complications were observed in all studied
patients. Procedural success of the patient with infrequent
PVCs was documented by the disappearance of these PVCs
following ablation even with isopretrenol infusion, this disap-
pearance was assured by Holter recording 48 h after ablation.
The site of successful ablation was found to be septal in ten
(62%) patients, free wall in three (19%) patients but not local-
ized in the remaining three patients (19%) with failed RFA.
The average procedure time was 118.12 ± 50.42 (35.00–
200.00) min beginning from puncturing to removal of the
sheath. The average Watts used for ablation is 33.44 ± 2.39
(30.00–35.00). All patients were followed up for a mean period
of 13.25 ± 7.8 (6–30) months. During follow-up there was sig-
niﬁcant reduction in the number and percentage of culprit
RVOT-PVCs in all patients with acute success for 48 h, 3
and 6 months after ablation (p= 0.001).
The number of PVCs decreased from 25640.50 ± 17461.55/
24 h. before ablation to 928 ± 441/24 h. in 48 h after ablation,
892 ± 408/24 h. in 3 months after ablation and 857 ± 389/
24 h. in 6 months after ablation. The percentage of PVCs de-
creased from 21 ± 9.48 before ablation to 0.84 ± 0.4 in the
48 h after ablation, 0.78 ± 0.36 in 3 months after ablation
and 0.68 ± 0.32 in 6 months after ablation (Fig. 2).
There was nonsigniﬁcant correlation between EDD and
percentage or total number of PVCs before ablation
(p value = 0.252). There was signiﬁcant positive correlation
between ESD and total number of PVCs before ablation,
(r= 0.490, p= 0.01), (Fig. 3). There was signiﬁcant positive
correlation between ESD and percentage of PVCs before abla-
tion, (r= 0.476, p= 0.015), (Fig. 4). There was a signiﬁcantm Maximum Mean Std. D.
53.00 34.63 12.82
46 25.13 11.43
66 57.06 5.34
57 42.81 7.32
52 45.19 5.85
82,753 25640.50 17461.55
212,418 117083.81 29960.03
39.00 21.31 9.48
action; PVC, premature ventricular contraction.
Figure 3 Signiﬁcant positive correlation between ESD and total number of PVCs before ablation (r= 0.490, p= 0.01).
Figure 2 Shows a high signiﬁcant reduction in PVCs% 48 h, 3 and 6 months following successful RFA when compared with pre-
ablation PVCs% (p= 0.002).
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EF before ablation (r= 0.587, p= 0.002), (Fig. 5). There
was a signiﬁcant inverse correlation between percentage of
PVCs and the EF before ablation (r= 0.505, p= 0.008),
(Fig. 6).
In the thirteen patients with successful RFA, there was a
high signiﬁcant reduction in EDD and ESD 3 & 6 months after
ablation when compared with the baseline measures (Figs. 7
and 8), (Table 2) On the other hand, a highly signiﬁcant
improvement was observed in EF in all patients with successful
RFA when compared with baseline EF (Fig. 9), (Table 2).
NYHA functional class improved in all patients with success-
ful ablation (11 patients were in NYHA class II and 2 in
NYHA class III improved to 12 patients in NYHA class 1
and 1 patient in NYHA class II (p= 0.004).Patients with unsuccessful RFA (three patients) did not
show any improvement in LVEF or decrease in LVESD in fol-
low up period. Also LVEDD and degree of mitral regurgita-
tion did not show any improvement but sometimes showed
deterioration especially in NYHA functional class (Table 3).6. Discussion
Radiofrequency catheter ablation has become a promising and
effective curative procedure for the treatment of symptomatic
idiopathic premature ventricular contractions originating from
the right ventricular outﬂow tract in patients without struc-
tural heart disease.9 However, there is a paucity of data on
the efﬁcacy and safety of radiofrequency catheter ablation
Figure 4 Signiﬁcant positive correlation between ESD and percentage of PVCs before ablation (r= 0.476, p= 0.015).
Figure 5 Signiﬁcant inverse correlation between total number of PVCs and EF before ablation (r= -0.587, p= 0.002).
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to evaluate the outcome of RFCA as curative therapy for idi-
opathic RVOT-PVCs and its effect on the ventricular function
and left ventricular dimensions. The study also aimed to iden-
tify the extent of procedure-related complications. In the pres-
ent study, RFA procedure for RVOT-PVCs was performed in16 patients with LV dilation and/or dysfunction without overt
underlying structural heart disease. Acute success was achieved
in 13 (81%) of the patients, with no procedure related compli-
cations. All patients included in our study had PVCs-associ-
ated symptoms which were in the order of frequency:
dyspnea, syncope, palpitation and ﬁnally chest pain. All
Figure 6 Signiﬁcant inverse correlation between percentage of PVCs and EF before ablation (r= -0.505, p= 0.008).
Figure 7 Shows a high signiﬁcant reduction in EDD 3 and 6 months following successful RFA when compared with pre-ablation
EDD (p= 0.002).
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PVCs associated symptoms and they discontinued the antiar-
rhythmic agents after RFA. These ﬁndings regarding PVCs-
associated symptoms are similar to ﬁndings of Takemoto
et al.; however palpitation was the most frequent symptom
in their study.12
One patient in our series was complaining of chest pain sev-
eral years before his inclusion in our study, the history of this
patient revealed that he had two diagnostic coronary angiogra-
phy in 2 years period for the purpose of investigating his chest
pain and was found to be normal, however, since this was a
subjective main complain of the patient it was mentioned as
it was described by the patient. Chest pain in this patient dis-
appeared after successful ablation. On reviewing publicationssome patients in other series were complaining of chest
pain.3,11–13 The exact cause for chest pain in patients with
PVCs is not clear. A decreased effective cardiac output could
be an explanation for this chest pain.3 Animal models have
shown that right ventricular pacing induces asymmetrical
myocardial hypertrophy, myoﬁbrillar disarray and increased
catecholamine concentrations in the myocardium that evoke
sympathoexcitation.14,15 which might be the cause of chest
pain in some individuals.
The percentage of acute success in our study was compara-
ble to the experience of other various centers, where success
rates have been reported between 75 and 100%.9 Darrieux
et al. achieved 77% success rate16 while van Huls van Taxis
et al. achieved 100% success.17
Figure 8 Shows a high signiﬁcant reduction in ESD 3 and 6 months following successful RFA when compared with pre-ablation ESD
(p= 0.005 and 0.002 respectively).
Figure 9 Shows a high signiﬁcant improvement in EF 3 and 6 months following successful RFA when compared with pre-ablation EF
(p= 0.001).
Table 2 Shows echocardiographic results (EDD, ESD, EF) pre, after 3 and 6 months of ablation.
Minimum Maximum Means ± Std. D. p-value
EDD pre. Abl. 40 66 56.62 ± 5.87
EDD after 3 months 40 62 51.08 ± 6.64 0.002
EDD after 6 months 40 56 49.23 ± 5.31 0.002
ESD pre. Abl. 24 57 41.85 ± 7.82
ESD after 3 months 26 50 35.92 ± 7.17 0.005
ESD after 6 months 26 41 33.31 ± 4.66 0.002
EF pre. Abl. 34 52 46.69 ± 4.92
EF after 3 months 41 71 57.15 ± 8.21 0.001
EF after 6 months 51 71 60.54 ± 5.39 0.001
EDD, end-diastolic diameter, ESD, end-systolic diameter, EF, ejection fraction, Abl., ablation.
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Table 3 Outcome of patients with unsuccessful RFA.
Patient no. EDD (mm) ESD(mm) EF (%) MR NYHA class
0 3m 6m 0 3m 6m 0 3m 6m 0 3m 6m 0 3m 6m
1 59 62 65 46 49 51 45 42 41 III III III III III IV
2 59 61 63 49 51 54 34 34 28 III III IV III IV IV
3 59 57 57 46 49 49 37 31 31 III III III III III IV
EDD, end-diastolic dimension; ESD, end-systolic dimension; EF, ejection fraction; MR, mitral regurgitation; m, month; NYHA, New York
Heart Association. 0 = pre-ablation, 3m = 3 months post-ablation, 6m= 6 months post-ablation.
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example the study target for Yarlagadda et al., and betensky
et al. was elimination of VPCs during the ablation and/or be-
came noninducible with programmed electrical stimulation
with or without isoprenaline infusion.18,10 The same target
was used by Takemoto et al. with the addition of nonrecur-
rence of PVCs for 72 h after ablation.12 For Sekiguchi et al.
the study target was reduction in PVCs to <1000 per day,19
and for Baman et al. it was 80% reduction in PVC burden.20
Ge et al. studied the biggest number of cases, 553 patients
with idiopathic PVCs/VT treated with RFA, 104 of them
where having PVCs/VT originating from the RVOT. In his
study he used PVCS <10 beats in 30 min as one of indicators
of short term success of RF ablation.11 The involvement of this
indictor by Ge et al. was very helpful during determining the
end point of success in our study, this is because in one of
the cases of our study RF ablation diminished the frequency
of PVCs dramatically but did not abolish it completely in spite
of several supplementary ablation points on and around the
target site, this case cannot be considered unsuccessful but with
the Ge et al. indicator it was included among the successful
cases. Isoprenaline administration after ablation as well as
Holter recording 48 h after the procedure were used to verify
whether PVCs diminution was a coincidental change in the
PVCs frequency or a true actual success.
Infrequent noninducible tachycardia is a source of difﬁculty
during RFA.21 In our series one patient had infrequent PVCs
during the procedure in spite of isoprenaline infusion, evidence
of success in this case was also determined by disappearance of
the PVCs after ablation with isoprenaline infusion, which was
also assured by Holter recording 48 h after the procedure. If
the PVCs were absent at the time of the study the patient
would be canceled.
Regarding PVCs burden, we think that the use of percent-
age of PVCs to total beats may represent more clearly the
PVCs burden than their total number; a similar number of
PVCs in two patients with different number of total heart beats
will have different PVCs’ percentage and subsequently differ-
ent PVC burdens. Some investigators used the absolute num-
ber of PVCs to deﬁne its frequency22,23 while others used the
percentage of PVCs to total heart beats20,24 therefore we rep-
resented both results for differentiation.
At the time of initial clinical presentation our patient’s ini-
tial data showed that the higher the percentage and total num-
ber of PVCs the lower the LVEF and the larger the ESD.
Several studies showed that the frequency of PVCs correlates
at least modestly with the extent of LV dysfunction and ven-
tricular dilation. Patients with decreased LVEF had a higher
mean PVC burden than their counterparts with normal LV
function. However, there are no clear-cut points that markthe frequency at which cardiomyopathy is unavoidable.
Niwano et al. used a cut point of 20 000 PVCs/day to deﬁne
the high-frequency group,22 whereas Kanei et al. used a ﬁgure
of 10 000 PVCs/day.23 Other studies deﬁned ‘‘frequent’’ PVCs
as >10% of total beats rather than the absolute number of
PVCs20,24 yet in some cases, a high PVC burden may not im-
pair LV function, whereas PVC-induced cardiomyopathy can
be observed in patients with lower PVC frequencies.25 It is
not known why the majority of patients with frequent PVCs
have a benign course, whereas up to one third of them develop
cardiomyopathy. One possible explanation is that the evalua-
tion of PVC burden using 24-h Holter monitoring may be
inadequate and may misrepresent the patient’s true PVC bur-
den.26 Baman et al. suggested that a PVC burden of >24%
had a sensitivity and speciﬁcity of 79% and 78%, respectively,
in separating the patient populations with impaired versus pre-
served LV function.20 Nevertheless, the majority of patients
presenting with frequent PVCs had preserved LVEF as stated
by some series.6,7,22,20 Therefore, although signiﬁcant, the PVC
burden is not the only factor contributing to impairment of LV
systolic function.27 In our study, the LVEDD and LVESD
have been reduced signiﬁcantly 3 months after successful abla-
tion (p= 0.002) as well as 6 months (0.005 and 0.002 respec-
tively). The ejection fraction improved signiﬁcantly after
successful PVCs ablation from 46.69 ± 4.92 pre-ablation to
57.15 ± 8.21 after 3 months from successful ablation and to
60.54 ± 5.39 after 6 months from ablation (p= 0.001). There
was also signiﬁcant improvement in NYHA functional class
and daily exercise capacity following ablation.
Patients in whom RFA was unsuccessful; EDD, ESD, EF,
degree of mitral regurgitation by echocardiogram and NYHA
functional class did not show improvement, on contraire they
showed some deterioration during follow-up (Table 3). This is
somewhat consistent with Bogun at al. 28 He found that abnor-
mal LVEF in patients with frequent idiopathic PVCs normal-
ized over a period of 6 months in 82% of patients after
successful ablation (from a baseline of 34%± 13% to
59%± 7%) (p< 0.0001) and ejection fraction declined fur-
ther in patients in whom ablation was ineffective (from
34%± 10% to 25%± 7%) (p= 0.06) during 6 months fol-
low-up. He also observed that patients with decreased LV
function had a greater PVC burden on a 24-h Holter monitor
than patients with normal EF, there was also a signiﬁcant in-
verse correlation between the PVC burden and the EF before
ablation. In his control group of 11 patients with a similar
PVC burden and a reduced EF who did not undergo ablation,
the EF remained unchanged in 10/11 patients over
19 ± 17 months of follow-up and one patient underwent heart
transplantation.28 Bogun et al. concluded that LV dysfunction
in the setting of frequent idiopathic PVCs may represent a
360 T. Basiouny et al.form of cardiomyopathy that can be reversed by catheter abla-
tion of the PVCs.
Lelakowski et al. reported improved quality of life in 22
patients who underwent PVCs ablation. They also observed
a negative correlation between PVCs load and quality of life.29
Inspite of small number of patients in his series (4 patients with
PVCs ablated from RV and 2 from LV) Taieb et al. stated that
elimination of frequent isolated PVCs in patients with dilated
cardiomyopathy with RFA can normalize the clinical status
and LV systolic function and dimensions, regardless of the
morphology or origin of the PVCs.25
In the present study during a mean follow up period of
13.25 ± 7.767 (6–30) months no recurrence of culprit
RVOT-PVCs was observed in all patients who underwent
RFA with acute successful result. This is consistent with
Yamashina et al. and Van Huls van Taxis et al.,30,17 taking
in consideration the relatively short follow up period.
The average procedure time in our studywas 118.12 ± 50.42
(35–200) min beginning from puncturing to pulling out the
sheath. This average procedure time is comparable with
Darrieux et al., who recorded an average time of 98 ± 37 min.16
The site of successful ablation in this study was found to be
septal in ten patients (62%), free wall in three patients (19%)
but not localized in the remaining three (19%) patients with
failed RFA. This is consistent with many publications (septal
location is more than free wall location).5,9,31
According to literatures approximately 10–15% of OT PVC
originates from the LVOT.32–35 In our series three cases ended
unsuccessfully, this might be due to epicardial or LVOT origin
of the PVCs. The ability to predict the site of origin of the
PVCs from the surface electrocardiogram by Betensky’s algo-
rithm has reached speciﬁcity of 100% and sensitivity of 92%, a
V2 transition ratio >0.6 predicts an LVOT origin with 91%
accuracy.10 He also stated that a PVC precordial transition
occurring later than the sinus rhythm transition excludes an
LVOT origin with 100% accuracy- which was the situation
in the three unsuccessful patients in our study. Since the aim
of our study was to deﬁne the effect of RVOT-PVC ablation
on LV function and size and not testing the accuracy of the
algorithms, ablating these PVCs from LVOT in those patients
would be beyond the scope of this study.
7. Limitations
In our study we used bipolar pacing during pace mapping and
not unipolar pacing, this would increase the surface area of the
capturing electrode and lead to pacing large area of myocar-
dium and hence to inaccuracy. However, this effect can be
minimized by not using high pacing outputs and by pacing
through a small interelectrode distance (65 mm).35 This was
achieved by the ablation catheter that had interelectrode dis-
tance of 5 mm and with pacing without exceeding double the
diastolic threshold.
8. Conclusion
The study concluded that RF catheter ablation of frequent
premature ventricular complexes from right ventricular out-
ﬂow tract (RVOT-PVCs) has a beneﬁcial effect on cardiac
function in patients with depressed cardiac function. Itconﬁrms a high degree of success and safety of radiofrequency
catheter ablation as a curative therapy for RVOT-PVCs.
Also it conﬁrms the positive correlation between RVOT-
PVCs burden and left ventricular dimensions and function in
patients without overt underlying structural heart disease.
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